Get the Stockscreener App
3.785
0.11%
0.005
Rocket Pharmaceuticals Inc stock is traded at $3.785, with a volume of 493.17K.
It is up +0.11% in the last 24 hours and up +16.07% over the past month.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.78
Open:
$3.78
24h Volume:
493.17K
Relative Volume:
0.14
Market Cap:
$408.96M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.3764
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
+1.18%
1M Performance:
+16.07%
6M Performance:
-50.41%
1Y Performance:
-77.70%
1-Day Range:
$3.72
$3.84
1-Week Range:
$3.72
$4.07
52-Week Range:
$2.19
$18.17
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals Inc
Sector
Industry
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.79 | 407.88M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.80 | 106.97B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
658.48 | 68.62B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.18 | 63.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
815.88 | 50.61B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.23 | 35.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-25-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-25 | Downgrade | Evercore ISI | Outperform → In-line |
| May-28-25 | Downgrade | Goldman | Neutral → Sell |
| May-28-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-28-25 | Downgrade | Jefferies | Buy → Hold |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| May-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-27-25 | Downgrade | Needham | Buy → Hold |
| May-27-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-12-25 | Initiated | BMO Capital Markets | Outperform |
| Dec-30-24 | Initiated | Wedbush | Outperform |
| Dec-18-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Apr-02-24 | Initiated | Goldman | Neutral |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-23 | Initiated | Morgan Stanley | Overweight |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Nov-01-22 | Initiated | BTIG Research | Buy |
| Jul-08-22 | Initiated | Raymond James | Outperform |
| Oct-20-21 | Resumed | Cowen | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
| Feb-18-21 | Initiated | Needham | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-08-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-02-20 | Initiated | JP Morgan | Overweight |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| Nov-06-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-26-19 | Initiated | Piper Jaffray | Overweight |
| Apr-23-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | BofA/Merrill | Buy |
| Feb-05-19 | Initiated | Oppenheimer | Outperform |
| Sep-13-18 | Initiated | Ladenburg Thalmann | Buy |
| Jul-10-18 | Initiated | William Blair | Outperform |
View All
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
Is Rocket Pharmaceuticals Inc. Equity Warrant stock poised for growthBear Alert & Low Drawdown Momentum Trade Ideas - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued historicallyEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock see insider accumulationJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock good for wealth creationTrade Ideas & Weekly Top Gainers Trade List - newser.com
Published on: 2025-10-30 05:17:46 - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock a safe haven assetEarnings Performance Report & Weekly Sector Rotation Insights - newser.com
Sentiment analysis tools applied to Rocket Pharmaceuticals Inc.New Guidance & Verified Swing Trading Watchlist - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryQuarterly Profit Summary & Smart Allocation Stock Reports - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant recovery potential after sell offWeekly Trade Review & Capital Efficient Trading Techniques - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts wealthy investors2025 Sector Review & Safe Investment Capital Preservation Plans - newser.com
Analyzing Rocket Pharmaceuticals Inc. Equity Warrant with risk reward ratio chartsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Rocket Pharmaceuticals Inc. stock chart pattern explainedEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Why Rocket Pharmaceuticals Inc. stock is in analyst buy zone2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Trading Recap & Reliable Breakout Forecasts - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock recover after recent dropWeekly Trend Summary & Entry Point Confirmation Signals - newser.com
What machine learning models say about Rocket Pharmaceuticals Inc.Weekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
What’s next for Rocket Pharmaceuticals Inc. stock price2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com
What dividend safety score for Rocket Pharmaceuticals Inc. stockInsider Selling & Verified Swing Trading Watchlist - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock compares to industry benchmarksTrade Exit Summary & Consistent Return Investment Signals - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant see short term momentumMarket Volume Summary & Weekly High Conviction Ideas - newser.com
Published on: 2025-10-29 03:40:12 - newser.com
Price momentum metrics for Rocket Pharmaceuticals Inc. explained2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com
Is Rocket Pharmaceuticals Inc. stock attractive for passive investorsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressuresDividend Hike & Risk Controlled Daily Trade Plans - newser.com
How to integrate Rocket Pharmaceuticals Inc. Equity Warrant into portfolio analysis toolsJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Published on: 2025-10-28 21:44:10 - newser.com
How Rocket Pharmaceuticals Inc. stock compares to industry benchmarksAnalyst Upgrade & Daily Oversold Bounce Ideas - Fundação Cultural do Pará
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Rocket Pharmaceuticals, Inc. (RCKT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to oil prices2025 Major Catalysts & Long-Term Growth Plans - Fundação Cultural do Pará
Will a bounce in Rocket Pharmaceuticals Inc. offer an exit2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc.Weekly Trading Summary & Expert Verified Movement Alerts - newser.com
What technical models suggest about Rocket Pharmaceuticals Inc.’s comebackTake Profit & Precise Swing Trade Entry Alerts - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts HNW investors2025 Retail Activity & Fast Gain Swing Trade Alerts - newser.com
Heatmap analysis for Rocket Pharmaceuticals Inc. Equity Warrant and competitorsNew Guidance & Intraday High Probability Alerts - newser.com
Does Rocket Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
Custom strategy builders for tracking Rocket Pharmaceuticals Inc.July 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com
Published on: 2025-10-28 02:19:15 - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock sustain double digit ROEWeekly Profit Summary & Technical Buy Zone Confirmations - Fundação Cultural do Pará
How institutional ownership impacts Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Can Rocket Pharmaceuticals Inc. Equity Warrant stock beat market expectations this quarterJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Why Rocket Pharmaceuticals Inc. stock remains on buy listsRate Hike & Safe Capital Growth Trade Ideas - newser.com
Rocket Pharmaceuticals Inc. recovery potential after sell offJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):